Optimized Self-Replicating RNA Enable Clinical Applications for Multiplexed Vaccines & Vectorized Biotherapeutics
- Optimizing self-replicating RNA vectors and manufacturing drive increases in immunogenicity and safety for a best-in-class therapeutic index
- Increased therapeutic index enable vaccines that target multiple respiratory pathogens and shorten development cycles
- srRNA are proving to enable a new class of vectorized biotherapeutics that enable multiplexed products with controllable PK profiles that can be re-dosed